NEW YORK (GenomeWeb News) – Cytometry workstation products developer Cyntellect has raised $15.5 million in a financing round that could total $18.6 million, according to a filing with the US Securities and Exchange Commission.
The San Diego-based firm offers a core technology that uses microplate-based cytometry to analyze cells for use in diagnostics and therapeutics.
Cyntellect's Celigo cytometer provides a label-free assay for in situ cell counting of live cells by imaging every cell within all areas of multi-well plates and culture flasks, which Cyntellect says cuts out the need for estimation or for forcing the cells into suspension.
The firm did not name the investors involved in the financing round so far.
As GenomeWeb Daily News reported in October, the company has recently opened a European sales office in Newport, UK that will have sales, scientific and service staff in France, Germany, and the Netherlands, and will support the entire EU.